BAVARO, LUANA
 Distribuzione geografica
Continente #
NA - Nord America 890
AS - Asia 575
EU - Europa 553
AF - Africa 63
SA - Sud America 32
OC - Oceania 1
Totale 2.114
Nazione #
US - Stati Uniti d'America 880
SG - Singapore 215
CN - Cina 118
IT - Italia 118
GB - Regno Unito 114
VN - Vietnam 113
DE - Germania 92
SE - Svezia 57
HK - Hong Kong 53
NL - Olanda 46
IE - Irlanda 34
IN - India 32
BR - Brasile 25
RU - Federazione Russa 24
TG - Togo 22
FR - Francia 20
CI - Costa d'Avorio 15
JO - Giordania 15
FI - Finlandia 11
ZA - Sudafrica 11
NG - Nigeria 9
EE - Estonia 8
ID - Indonesia 8
UA - Ucraina 7
CA - Canada 6
BG - Bulgaria 5
AR - Argentina 4
NO - Norvegia 4
TR - Turchia 4
AT - Austria 3
ES - Italia 3
IQ - Iraq 3
PL - Polonia 3
SC - Seychelles 3
BD - Bangladesh 2
CH - Svizzera 2
JP - Giappone 2
LB - Libano 2
MX - Messico 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
IR - Iran 1
KR - Corea 1
KW - Kuwait 1
MA - Marocco 1
MY - Malesia 1
PK - Pakistan 1
SA - Arabia Saudita 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
ZM - Zambia 1
Totale 2.114
Città #
Singapore 156
Chandler 115
Southend 102
Ashburn 101
Fairfield 80
Dong Ket 59
Hong Kong 50
Woodbridge 45
Seattle 44
Wilmington 44
Houston 42
Dublin 34
Cambridge 31
Princeton 30
Redmond 30
Beijing 26
Bologna 24
Lomé 22
Ho Chi Minh City 18
Santa Clara 16
Abidjan 15
Amman 15
Boardman 15
Hanoi 15
Los Angeles 13
Ann Arbor 12
Turin 11
Westminster 11
Berlin 10
Redondo Beach 10
Nanjing 9
Munich 8
Abeokuta 7
Dallas 7
Helsinki 7
Padova 7
Des Moines 6
Falkenstein 6
Milan 6
Changsha 5
Dearborn 5
Jakarta 5
Medford 5
Mountain View 5
Saint Petersburg 5
San Diego 5
Shenyang 5
Sofia 5
Amsterdam 4
Bareggio 4
Bremen 4
Florence 4
Forlì 4
Rome 4
São Paulo 4
Turku 4
Zhengzhou 4
Buffalo 3
Cernusco sul Naviglio 3
Chicago 3
Düsseldorf 3
Hebei 3
Jinan 3
London 3
New York 3
Nuremberg 3
Orem 3
Oslo 3
Taizhou 3
Tianjin 3
Toronto 3
Vienna 3
Warsaw 3
Ankara 2
Bern 2
Boydton 2
Cesena 2
Da Nang 2
Deventer 2
Ferrara 2
Francofonte 2
Gaomi 2
Haiphong 2
Hải Dương 2
Jiaxing 2
Latina 2
Mogliano Veneto 2
Montreal 2
Nanchang 2
Olalla 2
Phoenix 2
San Francisco 2
Shanghai 2
Stockholm 2
Thái Nguyên 2
Tokyo 2
Treviso 2
Argelato 1
As Sālimīyah 1
Baghdad 1
Totale 1.439
Nome #
Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors 192
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 185
BCR-ABL1 compound mutants: prevalence, spectrum and correlation with tyrosine kinase inhibitor resistance in a consecutive series of Philadelphia chromosome-positive leukemia patients analyzed by NGS 166
Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy 165
The 'Next-in-Cml' Study: A Prospective Multicenter Study of Deep Sequencing of the BCR-ABL1 Kinase Domain in Philadelphia Chromosome-Positive Patients with Non-Optimal Responses to Tyrosine Kinase Inhibitor Therapy 160
The Genomic and Transcriptomic Landscape of Systemic Mastocytosis 157
FOXM1 Transcription Factor: A New Component of Chronic Myeloid Leukemia Stem Cell Proliferation Advantage 148
BCR-ABL1 mutation screening in chronic myeloid leukaemia: is next now? 137
Ponatinib treatment in chronic myeloid leukemia cell lines targets aurora kinase A/FOXM1 axis 137
Polo-like Kinase-1 and Aurora Kinase A As Novel Therapeutic Targets in Neoplastic Mast Cells 134
In chronic myeloid leukemia patients on second-line tyrosine kinase inhibitor therapy, deep sequencing of BCR-ABL1 at the time of warning may allow sensitive detection of emerging drug-resistant mutants 132
Prospective assessment of NGS-detectable mutations in CML patients with non-optimal response: the NEXT-in-CML study 123
Next-generation sequencing improves BCR-ABL1 mutation detection in Philadelphia chromosome-positive acute lymphoblastic leukaemia 123
SETD2 Non-Genomic Loss of Function and p53 Functional Inactivation in Advanced Systemic Mastocytosis (SM): Pathogenetic and Therapeutic Implications 119
Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update 104
Totale 2.182
Categoria #
all - tutte 6.698
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.698


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021210 0 0 0 0 0 22 12 36 27 10 17 86
2021/2022252 15 4 19 9 28 19 5 21 13 17 57 45
2022/2023408 45 59 14 48 31 24 26 11 83 14 46 7
2023/202483 6 20 7 11 7 11 3 7 4 3 2 2
2024/2025379 22 65 43 23 30 11 24 27 5 54 12 63
2025/2026398 88 43 65 53 113 36 0 0 0 0 0 0
Totale 2.182